Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about Candel Therapeutics aggregated by PharmaCompass.com.

    Client Virtual Booth

    CANDEL THERAPEUTICS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Candel Therapeutics
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    117 Kendrick Street, Suite 450 Needham, Massachusetts 02494
    Telephone
    Telephone
    6179165445
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.candeltx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/candel-therapeutics/?viewAsMember=true
    Twitter
    Twitter
    https://twitter.com/CandelTx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Candel to Present at ASCO 2024 Annual Meeting
    Candel to Present at ASCO 2024 Annual Meeting

    https://www.globenewswire.com/news-release/2024/04/25/2869579/0/en/Candel-Therapeutics-Announces-Upcoming-Presentations-at-the-2024-ASCO-Annual-Meeting.html

    GLOBENEWSWIRE
    25 Apr 2024
    Share Share
    Candel Gets FDA Orphan Drug Status For Pancreatic Cancer Treatment
    Candel Gets FDA Orphan Drug Status For Pancreatic Cancer Treatment

    https://www.globenewswire.com/news-release/2024/04/11/2861549/0/en/Candel-Therapeutics-Receives-FDA-Orphan-Drug-Designation-for-CAN-2409-for-the-Treatment-of-Pancreatic-Cancer.html

    GLOBENEWSWIRE
    11 Apr 2024
    Share Share
    Candel Presents AACR Data on Solid Tumor Immunotherapy
    Candel Presents AACR Data on Solid Tumor Immunotherapy

    https://www.globenewswire.com/news-release/2024/04/09/2859909/0/en/Candel-Therapeutics-Presents-Preclinical-Data-at-AACR-on-Immunotherapy-Candidate-for-Induction-of-Tertiary-Lymphoid-Structures-in-Solid-Tumors.html

    GLOBENEWSWIRE
    09 Apr 2024
    Share Share
    Candel Announces Positive Data from Ph 2 Trial of CAN-2409 in Pancreatic Cancer
    Candel Announces Positive Data from Ph 2 Trial of CAN-2409 in Pancreatic Cancer

    https://www.globenewswire.com/news-release/2024/04/04/2857746/0/en/Candel-Therapeutics-Announces-Positive-Interim-Data-from-Randomized-Phase-2-Clinical-Trial-of-CAN-2409-in-Non-Metastatic-Pancreatic-Cancer.html

    GLOBENEWSWIRE
    04 Apr 2024
    Share Share
    Candel Announces Oral Presentation Update on Phase 1b Clinical Trial of CAN-3110
    Candel Announces Oral Presentation Update on Phase 1b Clinical Trial of CAN-3110

    https://www.globenewswire.com/news-release/2024/03/28/2854466/0/en/Candel-Therapeutics-Announces-Oral-Presentation-During-the-5th-Glioblastoma-Drug-Development-Summit-with-Update-on-Phase-1b-Clinical-Trial-of-CAN-3110-in-Recurrent-High-Grade-Gliom.html

    GLOBENEWSWIRE
    28 Mar 2024
    Share Share
    Candel Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
    Candel Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results

    https://www.globenewswire.com/news-release/2024/03/28/2853970/0/en/Candel-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Recent-Corporate-Highlights.html

    GLOBENEWSWIRE
    28 Mar 2024
    Share Share
    Candel Therapeutics Announces an Upcoming Presentation at the AACR
    Candel Therapeutics Announces an Upcoming Presentation at the AACR

    https://www.globenewswire.com//news-release/2024/03/05/2840948/0/en/Candel-Therapeutics-Announces-an-Upcoming-Presentation-at-the-AACR-Annual-Meeting-Unveiling-New-Cancer-Immunotherapy-Candidate.html

    GLOBENEWSWIRE
    05 Mar 2024
    Share Share
    CAN-3110 Receives FDA Fast Track Designation
    CAN-3110 Receives FDA Fast Track Designation

    https://www.globenewswire.com//news-release/2024/02/13/2828140/0/en/CAN-3110-Receives-FDA-Fast-Track-Designation-for-Treatment-of-Recurrent-High-Grade-Glioma.html

    GLOBENEWSWIRE
    13 Feb 2024
    Share Share
    Candel Therapeutics Sets Path to Success
    Candel Therapeutics Sets Path to Success

    https://www.globenewswire.com//news-release/2024/02/05/2823461/0/en/Candel-Therapeutics-Sets-Path-to-Success-Recent-Achievements-Pave-the-Way-for-a-Promising-2024-Propelled-by-Key-Value-Drivers-and-Catalysts.html

    GLOBENEWSWIRE
    05 Feb 2024
    Share Share
    Candel Receives FDA Fast Track Designation for CAN-2409 in Pancreatic Cancer
    Candel Receives FDA Fast Track Designation for CAN-2409 in Pancreatic Cancer

    https://www.globenewswire.com//news-release/2023/12/12/2794671/0/en/Candel-Therapeutics-Receives-FDA-Fast-Track-Designation-for-CAN-2409-in-Pancreatic-Cancer.html

    GLOBENEWSWIRE
    12 Dec 2023
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search